LCG
CDNA icon

Lisanti Capital Growth’s CareDx CDNA Stock Holding History

Lisanti Capital Growth’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-163,255
Closed -$14.9M – 141
2021
Q2 		$14.9M Buy
163,255
+46,725
+40% +$3.71M 1.85% 7
2021
Q1 		$7.93M Buy
116,530
+15,565
+15% +$1.21M 1.02% 38
2020
Q4 		$7.32M Buy
+100,965
New +$5.85M 1.01% 42
2020
Q3 		– Sell
-222,965
Closed -$7.9M – 120
2020
Q2 		$7.9M Buy
+222,965
New +$6.35M 1.61% 12
2019
Q3 		– Sell
-107,135
Closed -$3.86M – 99
2019
Q2 		$3.86M Buy
107,135
+54,975
+105% +$1.76M 1.25% 35
2019
Q1 		$1.64M Sell
52,160
-16,605
-24% -$484K 0.58% 77
2018
Q4 		$1.73M Buy
+68,765
New +$1.77M 0.7% 59

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Lisanti Capital Growth's CDNA Position: Q3 2021 in Review

Lisanti Capital Growth sold out of CareDx (CDNA) in Q3 2021, closing a stake of 163,255 shares — an estimated $14.9M sold.

Lisanti Capital Growth first reported a position in CDNA in Q4 2018 and held it in 7 quarters. The position peaked at $14.9M in Q2 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Lisanti Capital Growth reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Lisanti Capital Growth sold 163,255 CareDx shares in Q3 2021, an estimated $14.9M.
  • Lisanti Capital Growth first reported a position in CareDx in Q4 2018 and held it in 7 quarters.
  • Lisanti Capital Growth's CareDx position peaked at $14.9M in Q2 2021.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Lisanti Capital Growth's 13F filing for Q3 2021, filed 3 Nov 2021.